The present invention relates to novel thienopyhmidine compounds of general formula (I), pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
本发明涉及一类新型的
噻吩并
吡啶化合物,其具有通用公式(I),药物组合物包含这些化合物以及它们用于预防或治疗可以通过抑制Mnk1和/或Mnk2(Mnk2a或Mnk2b)及其变体的激酶活性来影响的疾病的疗法。